• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗疟药物的新趋势:抗肿瘤药物与抗疟药物对乳腺癌细胞的协同作用。

New Trends for Antimalarial Drugs: Synergism between Antineoplastics and Antimalarials on Breast Cancer Cells.

机构信息

OncoPharma Research Group, Center for Health Technology and Services Research (CINTESIS), Rua Plácido da Costa, 4200-450 Porto, Portugal.

Faculty of Pharmacy, University of Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal.

出版信息

Biomolecules. 2020 Dec 1;10(12):1623. doi: 10.3390/biom10121623.

DOI:10.3390/biom10121623
PMID:33271968
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7761440/
Abstract

Chemotherapy plays a key role in breast cancer therapy, but drug resistance and unwanted side effects make the treatment less effective. We propose a new combination model that combines antineoplastic drugs and antimalarials for breast cancer therapy. Cytotoxic effects of two antineoplastic agents alone and in combination with several antimalarials on MCF-7 tumor cell line was evaluated. Different concentrations in a fixed ratio were added to the cultured cells and incubated for 48 h. Cell viability was evaluated using MTT and SRB assays. Synergism was evaluated using the Chou-Talalay method. The results indicate doxorubicin (DOX) and paclitaxel (PTX) alone at concentrations of their IC and higher are cell growth inhibitors. Mefloquine, artesunate, and chloroquine at concentrations of their IC demonstrate anti-cancer activity. In combination, almost all antimalarials demonstrate higher ability than DOX and PTX alone to decrease cell viability at concentrations of IC and lower than their IC. The combination of chloroquine, artesunate and mefloquine with DOX and PTX was synergic (CI < 1). The combination of DOX and mefloquine after 48 h incubation demonstrated the highest cytotoxicity against MCF-7 cells, and the combination of DOX and artesunate was the most synergic. These results suggest antimalarials could act synergistically with DOX/PTX for breast cancer therapy.

摘要

化疗在乳腺癌治疗中起着关键作用,但耐药性和不良反应使治疗效果降低。我们提出了一种新的联合模型,将抗肿瘤药物和抗疟药物联合用于乳腺癌治疗。评估了两种抗肿瘤药物单独使用和与几种抗疟药物联合使用对 MCF-7 肿瘤细胞系的细胞毒性作用。在固定比例下加入不同浓度的培养液孵育 48 小时。用 MTT 和 SRB 法评估细胞活力。用 Chou-Talalay 法评估协同作用。结果表明,阿霉素(DOX)和紫杉醇(PTX)在其 IC 及其以上浓度时单独使用是细胞生长抑制剂。甲氟喹、青蒿琥酯和氯喹在其 IC 浓度时表现出抗癌活性。联合使用时,几乎所有的抗疟药物在 IC 及以下浓度时比 DOX 和 PTX 单独使用更能降低细胞活力,表现出更高的能力。氯喹、青蒿琥酯和甲氟喹与 DOX 和 PTX 的联合具有协同作用(CI < 1)。48 小时孵育后 DOX 和甲氟喹的联合表现出对 MCF-7 细胞最高的细胞毒性,而 DOX 和青蒿琥酯的联合则具有最高的协同作用。这些结果表明,抗疟药物可能与 DOX/PTX 协同作用,用于乳腺癌治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7701/7761440/e1084de02a60/biomolecules-10-01623-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7701/7761440/7b6a51479fb7/biomolecules-10-01623-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7701/7761440/7e8507cfdb2a/biomolecules-10-01623-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7701/7761440/e71f48c338a4/biomolecules-10-01623-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7701/7761440/69ad54a05a47/biomolecules-10-01623-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7701/7761440/39556eb80c63/biomolecules-10-01623-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7701/7761440/e1084de02a60/biomolecules-10-01623-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7701/7761440/7b6a51479fb7/biomolecules-10-01623-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7701/7761440/7e8507cfdb2a/biomolecules-10-01623-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7701/7761440/e71f48c338a4/biomolecules-10-01623-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7701/7761440/69ad54a05a47/biomolecules-10-01623-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7701/7761440/39556eb80c63/biomolecules-10-01623-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7701/7761440/e1084de02a60/biomolecules-10-01623-g007.jpg

相似文献

1
New Trends for Antimalarial Drugs: Synergism between Antineoplastics and Antimalarials on Breast Cancer Cells.抗疟药物的新趋势:抗肿瘤药物与抗疟药物对乳腺癌细胞的协同作用。
Biomolecules. 2020 Dec 1;10(12):1623. doi: 10.3390/biom10121623.
2
Synergistic Growth Inhibition of HT-29 Colon and MCF-7 Breast Cancer Cells with Simultaneous and Sequential Combinations of Antineoplastics and CNS Drugs.抗肿瘤药与中枢神经系统药物同时及序贯联合对HT-29结肠癌细胞和MCF-7乳腺癌细胞的协同生长抑制作用
Int J Mol Sci. 2021 Jul 10;22(14):7408. doi: 10.3390/ijms22147408.
3
Combination of Antimalarial and CNS Drugs with Antineoplastic Agents in MCF-7 Breast and HT-29 Colon Cancer Cells: Biosafety Evaluation and Mechanism of Action.抗疟药和中枢神经系统药物与抗肿瘤药物联合应用于 MCF-7 乳腺癌和 HT-29 结肠癌细胞:生物安全性评价及作用机制。
Biomolecules. 2022 Oct 16;12(10):1490. doi: 10.3390/biom12101490.
4
Enhancing therapeutic efficacy in breast cancer: a study on the combined cytotoxic effects of doxorubicin and MPC-3100.增强乳腺癌的治疗效果:多柔比星和 MPC-3100 联合细胞毒作用的研究。
Naunyn Schmiedebergs Arch Pharmacol. 2024 May;397(5):3249-3259. doi: 10.1007/s00210-023-02807-9. Epub 2023 Nov 2.
5
Liposomes co-encapsulating doxorubicin and glucoevatromonoside derivative induce synergic cytotoxic response against breast cancer cell lines.脂质体共包载阿霉素和葡萄糖醛酸基依瓦他莫苷衍生物对乳腺癌细胞系诱导协同细胞毒性反应。
Biomed Pharmacother. 2021 Apr;136:111123. doi: 10.1016/j.biopha.2020.111123. Epub 2021 Jan 22.
6
Enhanced lysosomal function is critical for paclitaxel resistance in cancer cells: reversed by artesunate.增强溶酶体功能对于癌细胞对紫杉醇的耐药性至关重要:青蒿琥酯可逆转这一现象。
Acta Pharmacol Sin. 2021 Apr;42(4):624-632. doi: 10.1038/s41401-020-0445-z. Epub 2020 Jul 23.
7
Drug Combinations: A New Strategy to Extend Drug Repurposing and Epithelial-Mesenchymal Transition in Breast and Colon Cancer Cells.药物组合:一种延长药物再利用和乳腺癌及结肠癌细胞上皮-间充质转化的新策略。
Biomolecules. 2022 Jan 23;12(2):190. doi: 10.3390/biom12020190.
8
Synergistic Cytotoxicity of Renieramycin M and Doxorubicin in MCF-7 Breast Cancer Cells.雷尼霉素 M 和阿霉素在 MCF-7 乳腺癌细胞中的协同细胞毒性。
Mar Drugs. 2019 Sep 16;17(9):536. doi: 10.3390/md17090536.
9
L-Canavanine Potentiates Cytotoxicity of Chemotherapeutic Drugs in Human Breast Cancer Cells.L-刀豆氨酸增强化疗药物对人乳腺癌细胞的细胞毒性。
Anticancer Agents Med Chem. 2017;17(2):206-211. doi: 10.2174/1871520616666160223111551.
10
Human pharmacokinetic characterization and in vitro study of the interaction between doxorubicin and paclitaxel in patients with breast cancer.乳腺癌患者中多柔比星与紫杉醇相互作用的人体药代动力学特征及体外研究
J Clin Oncol. 1997 May;15(5):1906-15. doi: 10.1200/JCO.1997.15.5.1906.

引用本文的文献

1
Selective Inhibition of the ABCG2 Transporter by Primaquine Derivatives Reverses the Multidrug Resistance of Tumor Cells.伯氨喹衍生物对ABCG2转运蛋白的选择性抑制可逆转肿瘤细胞的多药耐药性。
Int J Mol Sci. 2025 Jun 3;26(11):5367. doi: 10.3390/ijms26115367.
2
Exploration of innovative drug repurposing strategies for combating human protozoan diseases: Advances, challenges, and opportunities.探索用于对抗人类原生动物疾病的创新药物重新利用策略:进展、挑战与机遇
J Pharm Anal. 2025 Jan;15(1):101084. doi: 10.1016/j.jpha.2024.101084. Epub 2024 Aug 27.
3
Anti-tumor mechanism of artesunate.

本文引用的文献

1
Repositioning of Anthelmintic Drugs for the Treatment of Cancers of the Digestive System.抗蠕虫药物在消化系统癌症治疗中的再定位。
Int J Mol Sci. 2020 Jul 13;21(14):4957. doi: 10.3390/ijms21144957.
2
A curative combination cancer therapy achieves high fractional cell killing through low cross-resistance and drug additivity.一种有治疗作用的联合癌症疗法通过低交叉耐药性和药物协同作用实现高分数细胞杀伤。
Elife. 2019 Nov 19;8:e50036. doi: 10.7554/eLife.50036.
3
Antimalarial activity of primaquine operates via a two-step biochemical relay.伯氨喹的抗疟活性通过两步生化接力来实现。
青蒿琥酯的抗肿瘤机制。
Front Pharmacol. 2024 Oct 25;15:1483049. doi: 10.3389/fphar.2024.1483049. eCollection 2024.
4
Enhancing Urological Cancer Treatment: Leveraging Vasodilator Synergistic Potential with 5-FU for Improved Therapeutic Outcomes.增强泌尿系统癌症治疗效果:利用血管舒张剂与5-氟尿嘧啶的协同潜力以改善治疗结果。
J Clin Med. 2024 Jul 14;13(14):4113. doi: 10.3390/jcm13144113.
5
Chloroquine and Chemotherapeutic Compounds in Experimental Cancer Treatment.氯喹和化疗药物在癌症实验治疗中的应用。
Int J Mol Sci. 2024 Jan 12;25(2):945. doi: 10.3390/ijms25020945.
6
Fractions 14 and 36K of Metabolite Extract subsp. Hygroscopicus Have Antimalarial Activities Against in vitro.吸湿链霉菌亚种代谢物提取物的14K和36K组分对体外疟原虫具有抗疟活性。
Infect Drug Resist. 2023 May 12;16:2973-2985. doi: 10.2147/IDR.S400538. eCollection 2023.
7
The Involvement of Hypoxia in the Response of Neuroblastoma Cells to the Exposure of Atorvastatin.缺氧在神经母细胞瘤细胞对阿托伐他汀暴露反应中的作用
Curr Issues Mol Biol. 2023 Apr 11;45(4):3333-3346. doi: 10.3390/cimb45040218.
8
Improvement of the In Vitro Cytotoxic Effect on HT-29 Colon Cancer Cells by Combining 5-Fluorouacil and Fluphenazine with Green, Red or Brown Propolis.绿蜂胶、红蜂胶和棕蜂胶与 5-氟尿嘧啶和奋乃静联用对 HT-29 结肠癌细胞体外细胞毒性的增强作用
Molecules. 2023 Apr 12;28(8):3393. doi: 10.3390/molecules28083393.
9
Atorvastatin and Nitrofurantoin Repurposed in the Context of Breast Cancer and Neuroblastoma Cells.阿托伐他汀和呋喃妥因在乳腺癌和神经母细胞瘤细胞中的新用途
Biomedicines. 2023 Mar 15;11(3):903. doi: 10.3390/biomedicines11030903.
10
Antiparasitic Activity of Species and Synergistic Interaction between Montanine and Benznidazole against .物种的抗寄生虫活性以及蒙他宁与苄硝唑之间对……的协同相互作用
Microorganisms. 2023 Jan 6;11(1):144. doi: 10.3390/microorganisms11010144.
Nat Commun. 2019 Jul 19;10(1):3226. doi: 10.1038/s41467-019-11239-0.
4
Clinical utility of tafenoquine in the prevention of relapse of malaria: a review on the mode of action and emerging trial data.他非诺喹在预防疟疾复发中的临床应用:作用模式及新试验数据综述
Infect Drug Resist. 2019 Mar 6;12:553-570. doi: 10.2147/IDR.S151031. eCollection 2019.
5
ReDO_DB: the repurposing drugs in oncology database.ReDO数据库:肿瘤学领域药物重新利用数据库。
Ecancermedicalscience. 2018 Dec 6;12:886. doi: 10.3332/ecancer.2018.886. eCollection 2018.
6
The anti-malarial drug artesunate causes cell cycle arrest and apoptosis of triple-negative MDA-MB-468 and HER2-enriched SK-BR-3 breast cancer cells.抗疟药青蒿琥酯导致三阴性 MDA-MB-468 和 HER2 富集 SK-BR-3 乳腺癌细胞的细胞周期停滞和凋亡。
Exp Mol Pathol. 2019 Apr;107:10-22. doi: 10.1016/j.yexmp.2019.01.006. Epub 2019 Jan 17.
7
Pyronaridine exerts potent cytotoxicity on human breast and hematological cancer cells through induction of apoptosis.派隆那林通过诱导细胞凋亡对人乳腺癌和血液癌细胞发挥强大的细胞毒性作用。
PLoS One. 2018 Nov 5;13(11):e0206467. doi: 10.1371/journal.pone.0206467. eCollection 2018.
8
Anti-malarial atovaquone exhibits anti-tumor effects by inducing DNA damage in hepatocellular carcinoma.抗疟药阿托伐醌通过诱导肝细胞癌中的DNA损伤发挥抗肿瘤作用。
Am J Cancer Res. 2018 Sep 1;8(9):1697-1711. eCollection 2018.
9
Schedule dependent synergy of gemcitabine and doxorubicin: Improvement of in vitro efficacy and lack of in vitro-in vivo correlation.吉西他滨与阿霉素的给药方案依赖性协同作用:体外疗效的改善及体外-体内相关性的缺乏
Bioeng Transl Med. 2018 Jan 19;3(1):49-57. doi: 10.1002/btm2.10082. eCollection 2018 Jan.
10
Cancer statistics, 2018.癌症统计数据,2018 年。
CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.